Gender differences in the protective effects of green tea against amnestic mild cognitive impairment in the elderly Han population

References

• WilliamsJWPlassmanBLBurkeJBenjaminSPreventing Alzheimer’s disease and cognitive declineEvid Rep Technol Assess (Full Rep)20101931727
   Google Scholar
• ImtiazBTolppanenAMKivipeltoMSoininenHFuture directions in Alzheimer’s disease from risk factors to preventionBiochem Pharmacol201488466167024418410
   PubMed Web of Science ®Google Scholar
• PetersenRCSmithGEWaringSCIvnikRJTangalosEGKokmenEMild cognitive impairment: clinical characterization and outcomeArch Neurol199956330330810190820
   PubMed Web of Science ®Google Scholar
• PetersenRCAisenPSBeckettLAAlzheimer’s Disease Neuroimaging Initiative (ADNI): clinical characterizationNeurology201074320120920042704
   PubMed Web of Science ®Google Scholar
• ChengTOAll teas are not created equal: the Chinese green tea and cardiovascular healthInt J Cardiol2006108330130815978686
   PubMed Web of Science ®Google Scholar
• YangLJinXYanJPrevalence of dementia, cognitive status and associated risk factors among elderly of Zhejiang province, China in 2014Age Ageing201645570871227209328
   PubMed Web of Science ®Google Scholar
• TomataYSugiyamaKKaihoYGreen tea consumption and the risk of incident dementia in elderly Japanese: the Ohsaki Cohort 2006 StudyAm J Geriatr Psychiatry2016241088188927594507
   PubMed Web of Science ®Google Scholar
• IdeKYamadaHTakumaNGreen tea consumption affects cognitive dysfunction in the elderly: a pilot studyNutrients20146104032404225268837
   PubMed Web of Science ®Google Scholar
• KuriyamaSHozawaAOhmoriKGreen tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1Am J Clin Nutr200683235536116469995
   PubMed Web of Science ®Google Scholar
• ChoiYTJungCHLeeSRThe green tea polyphenol (−)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neuronsLife Sci200170560361411811904
   PubMed Web of Science ®Google Scholar
• XicotaLRodriguez-MoratoJDierssenMde la TorreRPotential role of (−)-Epigallocatechin-3-Gallate (EGCG) in the secondary prevention of Alzheimer diseaseCurr Drug Targets201718217419526302801
   PubMed Web of Science ®Google Scholar
• LindsayJLaurinDVerreaultRRisk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and AgingAm J Epidemiol2002156544545312196314
   PubMed Web of Science ®Google Scholar
• WangTXiaoSChenKPrevalence, incidence, risk and protective factors of amnestic mild cognitive impairment in the elderly in ShanghaiCurr Alzheimer Res201714446046627875948
   PubMed Web of Science ®Google Scholar
• XiaoSLiJTangMMethodology of China’s national study on the evaluation, early recognition, and treatment of psychological problems in the elderly: the China Longitudinal Aging Study (CLAS)Shanghai Arch Psychiatry2013252919824991140
   PubMedGoogle Scholar
• FolsteinMFFolsteinSEMcHughPR“Mini-mental state”: a practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res19751231891981202204
   PubMed Web of Science ®Google Scholar
• NasreddineZSPhillipsNABedirianVThe Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairmentJ Am Geriatr Soc200553469569915817019
   PubMed Web of Science ®Google Scholar
• YesavageJABrinkTLRoseTLDevelopment and validation of a geriatric depression screening scale: a preliminary reportJ Psychiatr Res198217137497183759
   PubMed Web of Science ®Google Scholar
• LawtonMPBrodyEMAssessment of older people: self-maintaining and instrumental activities of daily livingGerontologist1969931791865349366
   PubMed Web of Science ®Google Scholar
• ReisbergBFerrisSHde LeonMJCrookTThe Global Deterioration Scale for assessment of primary degenerative dementiaAm J Psychiatry19821399113611397114305
   PubMed Web of Science ®Google Scholar
• HachinskiVCIliffLDZilhkaECerebral blood flow in dementiaArch Neurol19753296326371164215
   PubMed Web of Science ®Google Scholar
• PetersenRCDoodyRKurzACurrent concepts in mild cognitive impairmentArch Neurol200158121985199211735772
   PubMed Web of Science ®Google Scholar
• GaoSHendrieHCHallKSHuiSThe relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysisArch Gen Psychiatry19985598098159736007
   PubMed Web of Science ®Google Scholar
• PovovaJAmbrozPBarMEpidemiological of and risk factors for Alzheimer’s disease: a reviewBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub2012156210811422837131
   PubMed Web of Science ®Google Scholar
• LuczajWSkrzydlewskaEAntioxidative properties of black teaPrev Med200540691091815850895
   PubMed Web of Science ®Google Scholar
• BastianettoSYaoZXPapadopoulosVQuirionRNeuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicityEur J Neurosci2006231556416420415
   PubMed Web of Science ®Google Scholar
• GrelleGOttoALorenzMFrankRFWankerEEBieschkeJBlack tea theaflavins inhibit formation of toxic amyloid-beta and alpha-synuclein fibrilsBiochemistry20115049106241063622054421
   PubMed Web of Science ®Google Scholar
• Noguchi-ShinoharaMYukiSDohmotoCConsumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive declinePLoS One201495e9601324828424
   PubMed Web of Science ®Google Scholar
• HenningSMNiuYLeeNHBioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplementAm J Clin Nutr20048061558156415585768
   PubMed Web of Science ®Google Scholar
• NgTPFengLNitiMKuaEHYapKBTea consumption and cognitive impairment and decline in older Chinese adultsAm J Clin Nutr200888122423118614745
   PubMed Web of Science ®Google Scholar
• WeinrebOMandelSAmitTYoudimMBNeurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseasesJ Nutr Biochem200415950651615350981
   PubMed Web of Science ®Google Scholar
• MandelSYoudimMBCatechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseasesFree Radic Biol Med200437330431715223064
   PubMed Web of Science ®Google Scholar
• HouRRChenJZChenHKangXGLiMGWangBRNeuroprotective effects of (−)-epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis in PC12 cellsCell Biol Int2008321223017936647
   PubMed Web of Science ®Google Scholar
• PanzaFSolfrizziVBarulliMRCoffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic reviewJ Nutr Health Aging201519331332825732217
   PubMed Web of Science ®Google Scholar
• HuangCQDongBRZhangYLWuHMLiuQXAssociation of cognitive impairment with smoking, alcohol consumption, tea consumption, and exercise among Chinese nonagenarians/centenariansCogn Behav Neurol200922319019619741330
   PubMed Web of Science ®Google Scholar
• NortonSMatthewsFEBarnesDEYaffeKBrayneCPotential for primary prevention of Alzheimer’s disease: an analysis of population-based dataLancet Neurol201413878879425030513
   PubMed Web of Science ®Google Scholar
• CarterCLResnickEMMallampalliMKalbarczykASex and gender differences in Alzheimer’s disease: recommendations for future researchJ Womens Health (Larchmt)201221101018102322917473
   PubMed Web of Science ®Google Scholar
• OrdonezCNavarroAPerezCMartínezEdel ValleEToliviaJGender differences in apolipoprotein D expression during aging and in Alzheimer diseaseNeurobiol Aging2012332433.e11e20
   Web of Science ®Google Scholar
• LiRSinghMSex differences in cognitive impairment and Alzheimer’s diseaseFront Neuroendocrinol201435338540324434111
   PubMed Web of Science ®Google Scholar
• MielkeMMVemuriPRoccaWAClinical epidemiology of Alzheimer’s disease: assessing sex and gender differencesClin Epidemiol20146374824470773
   PubMed Web of Science ®Google Scholar
• RoccaWAMielkeMMVemuriPMillerVMSex and gender differences in the causes of dementia: a narrative reviewMaturitas201479219620124954700
   PubMed Web of Science ®Google Scholar
• AustadSNBartkeASex differences in longevity and in responses to anti-aging interventions: a mini-reviewGerontology2015621404625968226
   PubMed Web of Science ®Google Scholar
• XingYTangYJiaJSex differences in neuropsychiatric symptoms of Alzheimer’s disease: the modifying effect of apolipoprotein E ε4 statusBehav Neurol2015201527525626538817
   PubMed Web of Science ®Google Scholar
• PodcasyJLEppersonCNConsidering sex and gender in Alzheimer disease and other dementiasDialogues Clin Neurosci201618443744628179815
   PubMed Web of Science ®Google Scholar
• BennettDAEditorial comment on “Prevalence of dementia in the United States: the aging, demographics, and memory study” by Plassman et alNeuroepidemiology2007291–213313517975327
   PubMed Web of Science ®Google Scholar
• AltmannATianLHendersonVWGreiciusMDAlzheimer’s Disease Neuroimaging Initiative InvestigatorsSex modifies the APOE-related risk of developing Alzheimer diseaseAnn Neurol201475456357324623176
   PubMed Web of Science ®Google Scholar
• GieddJNRaznahanAMillsKLLenrootRKReview: magnetic resonance imaging of male/female differences in human adolescent brain anatomyBiol Sex Differ2012311922908911
   PubMed Web of Science ®Google Scholar